---
sidebar_position: 1
sidebar_label: Fragile X Syndrome
pagination_next: null
pagination_prev: null
---

# Fragile X Syndrome

*The most common single-gene cause of autism*

## Overview

Fragile X Syndrome (FXS) is a genetic disorder caused by mutations in the FMR1 gene on the X chromosome. It is the most common inherited form of intellectual disability and the most frequent single-gene cause of autism spectrum disorder.

## Genetic Basis

- **Mutation type**: CGG trinucleotide repeat expansion in the FMR1 gene
- **Result**: Reduced or absent production of FMRP (Fragile X Mental Retardation Protein)
- **Inheritance**: X-linked dominant pattern
- **Prevalence**: Approximately 1 in 4,000 males and 1 in 8,000 females

## Connection to Autism

- **30-50%** of individuals with Fragile X meet criteria for autism
- **2-6%** of all autism cases are due to Fragile X Syndrome
- Shared features: social anxiety, repetitive behaviors, sensory sensitivities
- FMRP plays crucial role in synaptic plasticity and neuronal development

### Carrier Frequency and Implications

Carrier rates for FMR1 premutation are notably higher than the syndrome prevalence:
- **Females**: Approximately 1 in 150-250 are carriers
- **Males**: Approximately 1 in 400-800 are carriers

This carrier ratio aligns with the general autism male-to-female ratio of approximately 3:1. However, since Fragile X accounts for only 2-6% of autism cases—significantly lower than the overall autism prevalence of 3-5% in 2025—it cannot be considered a primary cause of autism. Nevertheless, the consistent male-to-female ratio may provide important clues for understanding the underlying mechanisms of autism spectrum disorders.

## Clinical Features

### Behavioral
- Social anxiety and gaze avoidance
- Repetitive behaviors and perseveration
- Attention deficits and hyperactivity
- Sensory processing difficulties

### Physical
- Elongated face and large ears
- Macroorchidism (enlarged testicles in males)
- Hyperflexible joints
- Soft skin

### Cognitive
- Intellectual disability (mild to severe)
- Impaired executive function
- Strengths in simultaneous processing
- Challenges with sequential processing

## Diagnosis

- **Genetic testing**: DNA analysis for FMR1 CGG repeats
- **Carrier screening**: Available for at-risk families
- **Prenatal testing**: Possible during pregnancy

## Treatment Approaches

### Current Interventions
- Early behavioral interventions (ABA, developmental approaches)
- Special education support
- Speech and occupational therapy
- Medications for attention and anxiety symptoms

### Emerging Therapies
- Targeted molecular therapies under investigation
- mGluR5 antagonists in clinical trials
- GABA modulators being studied

## Research Directions

- Understanding FMRP's role in synaptic function
- Developing drugs to restore protein synthesis regulation
- Identifying biomarkers for treatment response
- Gene therapy approaches

---

*This page will be updated as new research emerges.*